New Report: How Consolidation Fuels the Healthcare Affordability Crisis
A handful of corporate hospital systems now dominate most U.S. hospital care, leading to higher prices for consumers
Read More
That Discount at the Pharmacy Counter May Pack Hidden Costs
Next time you go to the pharmacy, you might be offered a coupon on your prescription drugs. While it may sound like a great deal — with the prospect of saving hundreds of dollars — the decision to accept it is complicated, especially for people with insurance. Even as prescription drug costs rise, patients with…
Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry. No surprise. About 60% of American adults are “worried about being able to afford prescription drug costs for themselves or their families,” a recent KFF nationwide poll showed. More…
Don’t Bury The Lead – AI Assisted Measures of Thymic Health Point to a “Fountain of Youth.”
By MIKE MAGEE In its final summary of the landmark paper in Nature this past month, the authors led with this statement: “This study underscores the highly personalized nature of thymic health and emphasizes the previously unrecognized possible critical role of maintaining thymic health to preserve an agile, adaptive immune response that will accommodate long-term…
Why don’t patients price shop for healthcare?
Stuart Figueroa provides some insights in his Incidental Economist article: To start, price shopping is inconvenient. It requires the consumer to invest time and energy in finding a provider, oftentimes having to navigate provider directories that are inaccurate, incomplete, or outdated. Price shopping is also hampered by the mere fact that health insurance is complicated and…
How PE Is Adjusting Its Healthcare Playbook Now that It’s Under the Microscope
Lawmakers are applying increased scrutiny to private equity’s involvement in healthcare, particularly when it comes to physician practice roll-ups. But investor Matthew Bennett argues the pressure is reshaping rather than shrinking the sector, pushing firms away from roll-ups and toward strategies focused on improving outcomes and using technology to boost efficiency. The post How PE…
Bayer Sees Opportunity With $300M Acquisition of Eye Drug Biotech
Perfuse Therapeutics brings Bayer an eye drug administered via an implant that controls the release of the therapy. This program is in mid-stage clinical development for glaucoma and diabetic retinopathy. The post Bayer Sees Opportunity With $300M Acquisition of Eye Drug Biotech appeared first on MedCity News.
Ben Salter, SafeRide Health
Ben Salter is the Chief Product Officer of SafeRide Health. They are one of the biggest players in non-emergency medical transport (NEMT) working predominantly for health plans that have Medicaid or Medicare Advantage members. Getting people to their appointments is a big deal–think disabled or sick people who will miss clinical appointments if they can’t…
Startup Enabling Aging at Home Raises $6M, Gains New MA and Medicaid Partnerships
Rosarium Health’s seed round was led by Kalos Ventures, with support from ResilienceVC, Rock Health Capital, Symphonic Capital, American Family Insurance Institute for Corporate and Social Impact, Black Tech Nations Ventures and The Council. The post Startup Enabling Aging at Home Raises $6M, Gains New MA and Medicaid Partnerships appeared first on MedCity News.
Developing a Learning Health System Approach to Sepsis
University of Michigan’s Stephanie Taylor, M.D., M.S., describes building trials to test interventions vs. usual care